Screener
Artiva Biotherapeutics, Inc. ARTV Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
FAQ
- What is Artiva Biotherapeutics, Inc.'s restricted cash?
- Artiva Biotherapeutics, Inc. (ARTV) reported restricted cash of $461K in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s restricted cash changed year-over-year?
- Artiva Biotherapeutics, Inc.'s restricted cash decreased by 0.0% year-over-year, from $461K to $461K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s restricted cash?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s restricted cash has grown at a 33.7% compound annual growth rate (CAGR), from $258K to $461K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Artiva Biotherapeutics, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude